Acute myeloid leukemias (AMLs) are overlap** hematological neoplasms associated with
rapid onset, progressive, and frequently chemo-resistant disease. At diagnosis, classification …

Acute myeloid leukemia (AML) is a neoplasm of immature myeloid cells and is associated
with a wide variety of clinical presentations, morphological features, immunophenotypes …

Background Bone marrow cytology is required to make a hematological diagnosis,
influencing critical clinical decision points in hematology. However, bone marrow cytology is …

In this review, we discuss applications of flow cytometric immunophenoty** (FCI) in the
diagnostic evaluation and posttreatment monitoring of B and T lymphoblastic …

Abstract Purpose of Review Electronic health records (EHRs) contain valuable data for
identifying health outcomes, but these data also present numerous challenges when …

Activating mutations in FMS-like tyrosine kinase 3 (FLT3), including internal tandem
duplications (ITDs) and tyrosine kinase domain (TKD) mutations, are common in patients …

In 2016 a revision of the World Health Organization (WHO) classification of acute myeloid
leukemia (AML) was introduced that included changes to several disease categories. The …

Opinion statement Improvements in systemic therapy in the treatment of acute lymphoblastic
leukemia (ALL) and acute myeloid leukemia (AML) have improved patient outcomes and …

Acute myeloid leukemia (AML) is a heterogeneous disease. Until recently, treatment for
patients with AML was limited to induction chemotherapy with cytarabine and anthracycline …

Objectives To describe the needs and formal assessment of family caregivers and ways to
intervene to alleviate distress and enhance caregiving skills in the setting of adult and …